Guangzhou Wondfo Biotech Co.,Ltd.’s Net Profit Rose 97% in First Three Quarters of 2022

Guangzhou Wondfo Biotech Co.,Ltd. (广州万孚生物技术股份有限公司) (300482.SZ) reported a net profit of 1.2 billion yuan in the first three quarters of 2022, up 97% year-on-year.

Meanwhile, the company posted 4.7 billion yuan in revenue, up 87.3% year-on-year.

At the end of the reporting period, it had 6.3 billion yuan in total assets and 1.6 billion yuan in total liabilities, with a liability-to-asset ratio of 25.5%.